🔥🐔 BizChicken 🐔🔥
Companies Similar to Nautilus Biotechnology, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
BioAtla, Inc.
BA3011
Bio Atla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Their lead product candidate is BA3011, targeting various cancers.
Symbol: BCAB
Recent Price: $0.59
Industry: Biotechnology
CEO: Dr. Jay M. Short Ph.D.
Sector: Healthcare
Employees: 65
Address: 11085 Torreyana Road, San Diego, CA 92121
Phone: 858 558 0708
Last updated: 2024-12-31
Sensei Biotherapeutics, Inc.
Immuno Phage platform
Sensei Biotherapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of immunotherapies for cancer, leveraging platforms such as Immuno Phage and Tumor Microenvironment Activated Biologics.
Symbol: SNSE
Recent Price: $0.48
Industry: Biotechnology
CEO: Mr. John K. Celebi M.B.A.
Sector: Healthcare
Employees: 28
Address: 451 D Street, Rockville, MD 02210
Phone: 240 243 8000
Last updated: 2024-12-31
Absci Corporation
Integrated Drug Creation Platform
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using an integrated drug creation platform for partners in the United States. Its platform enables the creation of biologics by unifying the drug discovery and cell line development processes.
About | About | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About
Symbol: ABSI
Recent Price: $2.65
Industry: Biotechnology
CEO: Mr. Sean McClain
Sector: Healthcare
Employees: 155
Address: 18105 SE Mill Plain Boulevard, Vancouver, WA 98683
Phone: 360 949 1041
Last updated: 2024-12-31
BioXcel Therapeutics, Inc.
IGALMI
Bio Xcel Therapeutics, Inc. is a biopharmaceutical company leveraging artificial intelligence for developing transformative medicines in neuroscience and immuno-oncology. It focuses on re-innovating existing drugs with machine learning to identify new therapeutic uses.
Symbol: BTAI
Recent Price: $0.37
Industry: Biotechnology
CEO: Dr. Vimal D. Mehta Ph.D.
Sector: Healthcare
Employees: 74
Address: 555 Long Wharf Drive, New Haven, CT 06511
Phone: 475 238 6837
Last updated: 2024-12-31
Maravai LifeSciences Holdings, Inc.
Nucleic Acids and Biologics Safety Testing Products
Maravai Life Sciences Holdings, Inc. is a life sciences company that provides products for drug therapies, diagnostics, novel vaccines, and research on human diseases, serving both the United States and international markets.
Symbol: MRVI
Recent Price: $5.51
Industry: Biotechnology
CEO: Mr. William E. Martin III
Sector: Healthcare
Employees: 580
Address: 10770 Wateridge Circle, San Diego, CA 92121
Phone: 858 546 0004
Last updated: 2024-12-31
Nautilus Biotechnology, Inc.
Nautilus Platform
Nautilus Biotechnology, Inc. is a development stage life sciences company that engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It was founded in 2016 and is headquartered in Seattle, Washington.
Symbol: NAUT
Recent Price: $1.67
Industry: Biotechnology
CEO: Mr. Sujal M. Patel
Sector: Healthcare
Employees: 161
Address: 2701 Eastlake Avenue East, Seattle, WA 98102
Phone: 206 333 2001
Last updated: 2024-12-31
NeuroBo Pharmaceuticals, Inc.
ANA001
A clinical-stage biotechnology company developing therapies for neurodegenerative, infectious, and cardiometabolic diseases.
Symbol: NRBO
Recent Price: $2.36
Industry: Biotechnology
CEO: Mr. Hyung-Heon Kim
Sector: Healthcare
Employees: 8
Address: 200 Berkeley Street, Boston, MA 02116
Phone: 857 702 9600
Last updated: 2024-12-31
Nurix Therapeutics, Inc.
NX-2127, NX-5948, NX-1607, NX-0255
Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.
Symbol: NRIX
Recent Price: $18.64
Industry: Biotechnology
CEO: Dr. Arthur T. Sands M.D., Ph.D.
Sector: Healthcare
Employees: 284
Address: 1700 Owens Street, San Francisco, CA 94158
Phone: 415 660 5320
Last updated: 2024-12-31
Palisade Bio, Inc.
LB1148
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing oral therapies targeting serious diseases related to the breakdown of the gastrointestinal mucosal barrier. Their lead product, LB1148, is designed to protect gut integrity during intestinal stress.
Symbol: PALI
Recent Price: $1.70
Industry: Biotechnology
CEO: Mr. J. D. Finley
Sector: Healthcare
Employees: 9
Address: 5800 Armada Drive, Carlsbad, CA 92008
Phone: 858 704 4900
Last updated: 2024-12-31
Puma Biotechnology, Inc.
PB272 (neratinib, oral)
Puma Biotechnology, Inc. focuses on the development and commercialization of products to enhance cancer care, with drug candidates including PB272 neratinib for various stages and types of cancer, and has various license agreements for its product distribution.
Symbol: PBYI
Recent Price: $3.13
Industry: Biotechnology
CEO: Mr. Alan H. Auerbach
Sector: Healthcare
Employees: 185
Address: 10880 Wilshire Boulevard, Los Angeles, CA 90024
Phone: 424 248 6500
Leadership
- Alan H. Auerbach, President and Chairman of the Board
- Maximo F. Nougues, Chief Financial Officer
- Jeff J. Ludwig, Chief Commercial Officer
- Douglas Hunt, B.Sc (Hons), Senior Vice President, Regulatory Affairs, Pharmacovigilance, Medical Affairs and Law
Last updated: 2024-12-31
Personalis, Inc.
NeXT Platform
Personalis, Inc. is a cancer genomics company that provides sequencing and data analysis services for cancer therapy development and genetic research. Their products include NeXT Platform, NeXT Liquid Biopsy, NeXT Personal, NeXT Dx Test, and ACE platform, serving biopharmaceutical, academic, and government institutions.
About | Contact | Contact | Contact | Careers | Careers | Careers | About | About | Careers | About | About | About
Symbol: PSNL
Recent Price: $5.97
Industry: Medical - Diagnostics & Research
CEO: Mr. Christopher M. Hall
Sector: Healthcare
Employees: 223
Address: 1330 O’Brien Drive, Menlo Park, CA 94025
Phone: 650 752 1300
Last updated: 2024-12-31
REGENXBIO Inc.
NAV Technology Platform
REGENXBIO Inc. is a biotechnology company focusing on gene therapy product candidates to treat genetic defects and enable therapeutic protein production, using its proprietary NAV Technology Platform. Its lead candidate, RGX-314, is in Phase III trials for wet age-related macular degeneration.
Symbol: RGNX
Recent Price: $7.23
Industry: Biotechnology
CEO: Mr. Curran M. Simpson M.S.
Sector: Healthcare
Employees: 344
Address: 9804 Medical Center Drive, Rockville, MD 20850
Phone: 240 552 8181
Last updated: 2024-12-31
Sana Biotechnology, Inc.
N/A
Sana Biotechnology, Inc. focuses on utilizing engineered cells as medicines, developing cell engineering platforms for various therapeutic areas including oncology, diabetes, and genetic disorders.
Symbol: SANA
Recent Price: $1.61
Industry: Biotechnology
CEO: Dr. Steven D. Harr M.D.
Sector: Healthcare
Employees: 328
Address: 188 East Blaine Street, Seattle, WA 98102
Phone: 206 701 7914
Last updated: 2024-12-31
Seer, Inc.
Proteograph Product Suite
Seer, Inc. is a life sciences company focused on developing and commercializing products to decode the secrets of the proteome. It offers the Proteograph Product Suite, enabling proteomic research for therapeutic and diagnostic studies.
About | Events | About | About | About | News | Locations | About | About | About | About | Careers | About | About | About
Symbol: SEER
Recent Price: $2.27
Industry: Biotechnology
CEO: Dr. Omid C. Farokhzad M.D., Ph.D.
Sector: Healthcare
Employees: 147
Address: 3800 Bridge Parkway, Redwood City, CA 94065
Phone: 650 453 0000
Last updated: 2024-12-31
Titan Pharmaceuticals, Inc.
Pro Neura
Titan Pharmaceuticals, Inc. is a pharmaceutical company developing therapeutics for chronic diseases utilizing the Pro Neura drug delivery platform. Its products include the Probuphine implant for opioid use disorder treatment, among other programs for chronic pruritus, opioid relapse prevention, HIV prevention, and contraception.
About | About | Leadership | Directors | About | Contact | Directors | Directors | Directors | Careers | About
Symbol: TTNP
Recent Price: $3.40
Industry: Biotechnology
CEO: Jennifer Kiernan
Sector: Healthcare
Employees: 4
Address: 400 Oyster Point Boulevard, South San Francisco, CA 94080-1958
Phone: 650 244 4990
Leadership
- Dato’ Seow Gim Shen, Chief Executive Officer and Chairman of the Board of Directors
- Avraham Ben-Tzvi, Founder
- Brynner Chiam, Vice President of Finance and Tax
- Firdauz Edmin Bin Mokhtar, Chief Executive Officer
- Francisco Osvaldo Flores García, Managing Partner
Last updated: 2024-12-31
Unity Biotechnology, Inc.
UBX1325
Unity Biotechnology, Inc. engages in the research and development of therapeutics aimed at slowing, halting, or reversing diseases of aging with a focus on eye-related conditions.
Symbol: UBX
Recent Price: $0.96
Industry: Biotechnology
CEO: Dr. Anirvan Ghosh Ph.D.
Sector: Healthcare
Employees: 19
Address: 285 East Grand Avenue, South San Francisco, CA 94080
Phone: 650 416 1192
Last updated: 2024-12-31
Ginkgo Bioworks Holdings, Inc.
platform for cell programming
Ginkgo Bioworks Holdings, Inc. develops a platform used to program cells for biological production of products such as therapeutics, food ingredients, and chemicals. It serves markets in specialty chemicals, agriculture, food, consumer products, and pharmaceuticals.
About | About | Contact | Contact | About | About | About | About | Vision/Values | About | About | About | Culture | About | Careers | About | About | About
Symbol: DNA
Recent Price: $9.44
Industry: Biotechnology
CEO: Dr. Jason Kelly
Sector: Healthcare
Employees: 1218
Address: 27 Drydock Avenue, Boston, MA 02210
Phone: 877 422 5362
Last updated: 2024-12-31
Nuvation Bio Inc.
NUV-422
Nuvation Bio Inc. is a clinical-stage biopharmaceutical company focusing on the development of therapeutic candidates for oncology, such as NUV-422, a small molecule inhibitor targeting cyclin-dependent kinases, among other innovative treatments.
Symbol: NUVB
Recent Price: $2.62
Industry: Biotechnology
CEO: Dr. David T. Hung M.D.
Sector: Healthcare
Employees: 51
Address: 1500 Broadway, New York, NY 10036
Phone: 332 208 6102
Last updated: 2024-12-31
BioLife Solutions, Inc.
bioproduction tools and services
Bio Life Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services essential for the cell and gene therapy industry globally. The company's offerings include biopreservation media products, automated thawing products, cloud-connected shipping containers, and storage solutions for biologics and pharmaceuticals.
About | Events | Leadership | Leadership | Management | About | About | News | Contact | Contact | Contact | Contact | Contact | About | About | About | About | About
Symbol: BLFS
Recent Price: $26.27
Industry: Medical - Instruments & Supplies
CEO: Mr. Roderick de Greef
Sector: Healthcare
Employees: 409
Address: 3303 Monte Villa Parkway, Bothell, WA 98021
Phone: 425 402 1400
Leadership
- Rod de Greef, Chairman & Chief Executive Officer
- Aby J. Mathew, Ph.D., Executive Vice President and Chief Scientific Officer
- Karen Foster, Chief Quality and Operations Officer
- Troy Wichterman, Chief Financial Officer
- Todd Berard, Chief Marketing Officer
- Garrie Richardson, Chief Revenue Officer
- Sarah Aebersold, Chief Human Resources Officer
- Mike Pallotta, Global VP, Hardware and Electrical Engineering
- Brett Stucker, VP of Cybersecurity and Information Security Officer
- Amy DuRoss,
- Rachel Ellingson,
- Joydeep Goswami, MBA, Ph.D.,
- Tim Moore,
- Joseph Schick, Chairman – Audit Committee
- Andrew Hinson,
- Anthony Davies, Ph.D.,
- Colleen Delaney, M.D., M.Sc.,
- Dayong Gao, Ph.D.,
- Erik Woods, Ph.D., HCLD(ABB),
- Jon Rowley, Ph.D.,
- John McMannis, Ph.D.,
- Jerry E. Cooley, M.D.,
- Jason Acker, MBA, Ph.D.,
- Lizabeth Cardwell, MT (ASCP), MBA, RAC,
- Scott R. Burger, M.D.,
- Shelly Heimfeld, Ph.D.,
Last updated: 2024-12-31
Denali Therapeutics Inc.
BIIB122/DNL151
Denali Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing therapeutic candidates for neurodegenerative diseases. Its pipeline includes treatments for Parkinson's disease, hunter syndrome, ALS, multiple sclerosis, and Alzheimer's disease. It collaborates with companies such as Takeda Pharmaceutical Company and Genentech, Inc.
Symbol: DNLI
Recent Price: $20.24
Industry: Biotechnology
CEO: Dr. Ryan J. Watts Ph.D.
Sector: Healthcare
Employees: 364
Address: 161 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 650 866 8548
Last updated: 2024-12-31